Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Abstract Background Vedolizumab has become a standard treatment for the inflammatory bowel diseases ulcerative colitis (UC) and Crohn’s disease (CD). However, there is an ongoing debate on the ideal individual treatment algorithms and means to predict treatment response are not routinely established...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
BMC
2021-01-01
|
| 丛编: | BMC Gastroenterology |
| 主题: | |
| 在线阅读: | https://doi.org/10.1186/s12876-021-01604-z |
| 标签: |
没有标签, 成为第一个标记此记录!
|